Updated Guidance for COVID-19 Convalescent Plasma Use from the FDA and AABB With a lack of effective treatments for COVID-19, the U.S. FDA issued Emergency Use Authorization to use convalescent plasma to… February 17, 2021
Early Convalescent Plasma Therapy Helps Prevent Severe COVID-19 COVID-19 convalescent plasma administered late in the course of disease has not shown clear benefits, but some studies suggest that… January 12, 2021
Cochrane Living Systematic Review: More Data Needed to Determine Efficacy of COVID-19 Convalescent Plasma Researchers from the Cochrane Library are performing monthly systematic reviews to evaluate the current data on the effectiveness of COVID-19… October 28, 2020
COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19… September 30, 2020
NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma On September 1, 2020, shortly after the U.S. Food and Drug’s Emergency Use Authorization (EUA) for the use of COVID-19… September 9, 2020
FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use… August 25, 2020
Convalescent Plasma Is Safe and Likely Efficacious for Patients with COVID-19 There are limited therapeutic options to treat COVID-19, and COVID-19 convalescent plasma (CCP) is currently one of the most common… August 4, 2020
Convalescent Plasma Decreases Mortality for Non-Intubated Patients with Severe COVID-19 Based on a preliminary propensity score-matched control study, convalescent plasma is beneficial for non-intubated patients with severe COVID-19. At the… May 27, 2020
Convalescent Plasma for COVID-19 Safe in First 5,000 Patients With limited therapies for patients with COVID-19 and a mortality rate of approximately 50% for patients in the ICU, demand… May 19, 2020
Coagulopathy in Patients with COVID-19—Interim Guidance from the International Society on Thrombosis and Haemostasis Although the pathophysiology of severe COVID-19 is poorly understood, coagulopathy near the lungs has been shown to play an important… May 13, 2020
Coagulation & Plasma Transfusion